New #foodsafety #recall #undeclared #milk #allergen and presence of Viagra drug in AMPT Coffee

The AMPT Life, LLC Issues Voluntary Nationwide Recall of AMPT Coffee due to the Presence of Undeclared Active Pharmaceutical Ingredients and Undeclared Milk

For Immediate Release

August 1, 2017

Contact

Consumers

 customerservice@amptcoffee.com.

Media

 214-838-7544

Announcement

The AMPT Life, LLC is voluntarily recalling all lots of AMPT Coffee to the consumer level. FDA laboratory analysis confirmed the presence of Sildenafil and Tadalafil, the active ingredient in Viagra, an FDA-approved prescription drug for Erectile Dysfunction (ED). AMPT Coffee also contains undeclared milk.

These undeclared ingredients may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels.  Men with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.  In addition, people who have an allergy or severe sensitivity to milk run the risk of serious or life threatening allergic reaction if they consume this product.

AMPT Coffee is used as a libido booster and is packaged in a red box and red packets with black writing, UPC 6942630912.  The AMPT Life, LLC distributed this product from April 2016 through March 2017.  AMPT Coffee is consumed as an instant coffee. AMPT Coffee was distributed nationwide to consumers via internet at www.amptcoffee.com.

The AMPT Life, LLC has not had any reports of injuries or illnesses to date.

The AMPT Life, LLC is notifying its customers by email. Consumers that have AMPT Coffee, which is being recalled, should stop using and discard any remaining coffee.

Consumers with questions regarding this recall can contact The AMPT Life, LLC at customerservice@amptcoffee.com. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

·Complete and submit the report Online: www.fda.gov/medwatch/report.htm

·Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

###